| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
ICU Medical (NASDAQ:ICUI) reported its Q4 earnings results on Tuesday, February 27, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
ICU Medical beat estimated earnings by 32.0%, reporting an EPS of $1.57 versus an estimate of $1.19.
Revenue was up $9.84 million from the same period last year.
Last quarter the company beat on EPS by $0.19 which was followed by a 17.0% drop in the share price the next day.
Here's a look at ICU Medical's past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | 1.38 | 1.55 | 1.43 | 1.56 |
| EPS Actual | 1.57 | 1.88 | 1.74 | 1.60 |
| Revenue Estimate | 565.75M | 562.90M | 565.30M | 578.77M |
| Revenue Actual | 553.31M | 549.31M | 568.65M | 578.01M |
To track all earnings releases for ICU Medical visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: ICUI
